Literature DB >> 8033335

Active cytomegalovirus infection of arterial smooth muscle cells in immunocompromised rats. A clue to herpesvirus-associated atherogenesis?

M C Persoons1, M J Daemen, J H Bruning, C A Bruggeman.   

Abstract

The susceptibility of medial and neointimal arterial smooth muscle cells (SMCs) to acute cytomegalovirus (CMV) infection was investigated in immunocompetent and immunocompromised rats. The left common carotid artery of all the rats was injured by balloon catheterization. On days 14 and 17 after injury, rats were either intravenously infected with a rat CMV (RCMV) or mock-infected. Active RCMV infection was shown in the neointima of the injured arteries of immunosuppressed rats, characterized by specific cytopathological changes in hematoxylin-eosin-stained sections and by the presence of early viral antigens and the presence of the virus at different stages of maturation at the electron-microscopic level. Viral genome was shown as well by use of in situ hybridization procedures. However, medial cells were hardly ever infected, and RCMV did not infect neointimal parts that were recovered by endothelial cells. No infection was seen in control right carotid arteries or in the injured arteries of immunocompetent rats. Acute intimal RCMV infection was accompanied by infiltration of inflammatory cells, predominantly mononuclear cells that stained positive with an ED-1 monoclonal antibody. The majority of infected neointimal cells were SMCs containing smooth muscle actin. No changes were found in medial or neointimal cross-sectional areas of the infected arteries. In the present study, an active RCMV infection of arterial SMCs was established in vivo, and it was concluded that neointimal SMCs are far more susceptible than are medial SMCs and that the absence of endothelium and immunosuppression are necessary conditions for arterial RCMV infection.

Entities:  

Mesh:

Year:  1994        PMID: 8033335     DOI: 10.1161/01.res.75.2.214

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  7 in total

1.  Circulating nucleic acids of Chlamydia pneumoniae and cytomegalovirus in patients undergoing coronary angiography.

Authors:  M Smieja; S Chong; M Natarajan; A Petrich; L Rainen; J B Mahony
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 2.  Microorganisms in the aetiology of atherosclerosis.

Authors:  S A Morré; W Stooker; W K Lagrand; A J van den Brule; H W Niessen
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

3.  Impaired arterial reactivity following cytomegalovirus infection in the immunosuppressed rat.

Authors:  P H Eerdmans; M C Persoons; S J Debets; H A Struijker Boudier; J F Smits; C A Bruggeman; J G De Mey
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

Review 4.  Microbes, inflammation and atherosclerosis: will old pathology lessons guide new therapies?

Authors:  G M Vercellotti
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

5.  Cellular localization of latent murine cytomegalovirus.

Authors:  A J Koffron; M Hummel; B K Patterson; S Yan; D B Kaufman; J P Fryer; F P Stuart; M I Abecassis
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

Review 6.  [Cytomegalovirus and herpes simplex virus in pathogenesis and progression of native arteriosclerosis and recurrent stenosis after intervention].

Authors:  M Herzum; J R Schaefer; G Hufnagel; B Maisch
Journal:  Herz       Date:  1998-05       Impact factor: 1.443

7.  Enhanced cytomegalovirus infection in atherosclerotic human blood vessels.

Authors:  Pamela L Nerheim; Jeffery L Meier; Mohammad A Vasef; Wei-Gen Li; Ling Hu; James B Rice; Daniel Gavrila; Wayne E Richenbacher; Neal L Weintraub
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.